Related Experiment Video
Updated: Jun 17, 2026

07:57
A New Method for Inducing a Depression-Like Behavior in Rats
Published on: February 22, 2018
High Frequency of Depression in Advanced Cancer with Concomitant Comorbidities: A Registry Study
Peter Strang1,2, Torbjörn Schultz2
1Department of Oncology-Pathology, Karolinska Institutet, Stockholms Sjukhem Foundation, Mariebergsgatan 22, SE 112 19 Stockholm, Sweden.
Cancers
|April 14, 2025
Summary
Depression is common in advanced cancer, particularly in women and frail individuals. Early identification and management are crucial, as depression impacts healthcare needs and cancer prognosis.
Area of Science:
- Oncology
- Geriatrics
- Psychiatry
Background:
- Depression is a frequent complication in cancer patients, linked to distress and reduced treatment adherence.
- The exact prevalence of depression in advanced cancer remains unclear due to methodological challenges.
Purpose of the Study:
- To investigate the prevalence of depression in the final year of life among cancer patients.
- To identify variables associated with depression in this population, including age, sex, socioeconomic status, and frailty.
Main Methods:
- Analysis of an administrative database of clinically verified depression diagnoses in 27,343 individuals during their last year of life.
- Data were correlated with age, area-level socioeconomic status (Mosaic system), and Hospital Frailty Risk Score (HFRS).
- Statistical methods included t-tests, chi-2 tests, and binary logistic regression.
Main Results:
- A clinical diagnosis of depression was identified in 4.3% of patients.
- Depression was more prevalent in women (4.8% vs. 3.8%) and the elderly (≥80 years).
- A significant association was found between depression risk and frailty, with higher rates in intermediate (5.3%) and high-risk (7.8%) HFRS groups compared to low-risk (3.3%). No socioeconomic differences were observed.
Conclusions:
- Depression is more common in women and individuals with multimorbidity.
- Frailty, assessed by HFRS, is a strong predictor of depression in the last year of life.
- Clinical decision-making in cancer care should incorporate depression assessment due to its impact on healthcare needs and prognosis.
Related Concept Videos
Long-term Depression
30.4K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
30.4K
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
Depression: Overview
197
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
197
Psychoneuroimmunology: Diabetes and Cancer
19
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
19
Depressive Disorders: MDD and Dysthymia
17
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
17
Depressive Disorders: Etiology
19
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
19

